The medications at issue are the retailers’ versions of Johnson & Johnson Consumer Inc.'s Tylenol Extra Strength Rapid Release Gels, according to the complaints in the U.S. District Courts for Northern District of Illinois, and the Northern and Central Districts of California.
Federal law governing over-the-counter drugs preempts the suits, the companies said in Feb. 5 filings in the three courts.
The plaintiffs alleged they were tricked into believing that they ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.